Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergi Mas

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Translational Psychiatry|December 15, 2018
Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychoticsDaniel Boloc, Anna Gortat, Jia Qi Cheng-Zhang, et al.
Translational Psychiatry|May 8, 2023
Epigenetic age deacceleration in youth at familial risk for schizophrenia and bipolar disorderAlex G Segura, Elena de la Serna, Gisela Sugranyes, et al.
Psychiatry Research|January 10, 2024
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic riskLlucia Prohens, Natalia Rodríguez, Àlex-Gonzàlez Segura, et al.
Psychiatry Research|September 14, 2016
Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disordersPatricia Gassó, Vanessa Sánchez-Gistau, Sergi Mas, et al.
Frontiers in Psychiatry|January 22, 2025
Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocolSergi Mas, Laura Julià, Manuel J Cuesta, et al.
Spanish Journal of Psychiatry and Mental Health|July 2, 2025
Assessing cognitive reserve outcomes and biomarkers in first episode of psychosis: Rationale, objectives, protocol and preliminary results of the CRASH ProjectMiquel Bernardo, Gerard Anmella, Norma Verdolini, et al.
Translational Psychiatry|November 1, 2025
Association of astrocyte-specific gene expression in the dorsolateral prefrontal cortex with clozapine treatment in schizophreniaLlucia Prohens, Natalia Rodríguez, Àlex-Gonzàlez Segura, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 12, 2019
Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosisMiquel Bioque, Sergi Mas, Maria Cristina Costanzo, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 23, 2024
The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational studyEmilio Fernandez-Egea, Shanquan Chen, Estela Sangüesa, et al.
Psychological Medicine|April 27, 2026
Cognitive reserve in non-affective first-episode psychosis: contributions of polygenic scores, early clinical features, and environmentM Florencia Forte, Àlex G Segura, Maria Serra-Navarro, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Translational Psychiatry|December 15, 2018
Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychoticsDaniel Boloc, Anna Gortat, Jia Qi Cheng-Zhang, et al.
Translational Psychiatry|May 8, 2023
Epigenetic age deacceleration in youth at familial risk for schizophrenia and bipolar disorderAlex G Segura, Elena de la Serna, Gisela Sugranyes, et al.
Psychiatry Research|January 10, 2024
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic riskLlucia Prohens, Natalia Rodríguez, Àlex-Gonzàlez Segura, et al.
Psychiatry Research|September 14, 2016
Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disordersPatricia Gassó, Vanessa Sánchez-Gistau, Sergi Mas, et al.
Frontiers in Psychiatry|January 22, 2025
Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocolSergi Mas, Laura Julià, Manuel J Cuesta, et al.
Spanish Journal of Psychiatry and Mental Health|July 2, 2025
Assessing cognitive reserve outcomes and biomarkers in first episode of psychosis: Rationale, objectives, protocol and preliminary results of the CRASH ProjectMiquel Bernardo, Gerard Anmella, Norma Verdolini, et al.
Translational Psychiatry|November 1, 2025
Association of astrocyte-specific gene expression in the dorsolateral prefrontal cortex with clozapine treatment in schizophreniaLlucia Prohens, Natalia Rodríguez, Àlex-Gonzàlez Segura, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 12, 2019
Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosisMiquel Bioque, Sergi Mas, Maria Cristina Costanzo, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 23, 2024
The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational studyEmilio Fernandez-Egea, Shanquan Chen, Estela Sangüesa, et al.
Psychological Medicine|April 27, 2026
Cognitive reserve in non-affective first-episode psychosis: contributions of polygenic scores, early clinical features, and environmentM Florencia Forte, Àlex G Segura, Maria Serra-Navarro, et al.
Pageof 11